CEA and immunosuppression: investigation performed on patients with gastrointestinal advanced adenocarcinomas treated with immunochemotherapy.

: No statistically significant correlations were detected between plasma CEA levels, DNCB skin test responses, peripheral lymphocytes and plasma immunoglobulins in 90 patients with G.I. advanced adenocarcinomas, treated with BCG aspecific immunotherapy and chemoterapy.